(MYCOF) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

(MYCOF) Stock Quotes, Forecast and News Summary

MYCOF stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More

Lara Goldstein

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution

Lara Goldstein

Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market

Novel psychedelic-based drugs biotech Mydecine Innovations Group, Inc. (NEO:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NFA) completed its admission to Access segment of the UK’s stock market, AQSE Growth Market. Trading started on Tuesday under ticker MYIG.

Nina Zdinjak

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About

Sector

Healthcare

Industry

N/A

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, dru...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.